| Global prevalence of chronic kidney disease–a systematic review and meta-analysis NR Hill, ST Fatoba, JL Oke, JA Hirst, CA O’Callaghan, DS Lasserson, ... PloS one 11 (7), e0158765, 2016 | 4810 | 2016 |
| Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis JC Crocker, I Ricci-Cabello, A Parker, JA Hirst, A Chant, S Petit-Zeman, ... bmj 363, 2018 | 513 | 2018 |
| Quantifying the effect of metformin treatment and dose on glycemic control JA Hirst, AJ Farmer, R Ali, NW Roberts, RJ Stevens Diabetes care 35 (2), 446-454, 2012 | 273 | 2012 |
| The need for randomization in animal trials: an overview of systematic reviews JA Hirst, J Howick, JK Aronson, N Roberts, R Perera, C Koshiaris, ... PloS one 9 (6), e98856, 2014 | 268 | 2014 |
| Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis JA Hirst, AJ Farmer, A Dyar, TWC Lung, RJ Stevens Diabetologia 56, 973-984, 2013 | 263 | 2013 |
| Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials RJ Stevens, R Ali, CR Bankhead, MA Bethel, BJ Cairns, RP Camisasca, ... Diabetologia 55, 2593-2603, 2012 | 222 | 2012 |
| Performance of point-of-care HbA1c test devices: implications for use in clinical practice – a systematic review and meta-analysis JA Hirst, JH McLellan, CP Price, E English, BG Feakins, RJ Stevens, ... Clinical Chemistry and Laboratory Medicine (CCLM) 55 (2), 167-180, 2017 | 121 | 2017 |
| Point-of-Care Testing for Hb A1c in the Management of Diabetes: A Systematic Review and Metaanalysis L Al-Ansary, A Farmer, J Hirst, N Roberts, P Glasziou, R Perera, CP Price Clinical chemistry 57 (4), 568-576, 2011 | 108 | 2011 |
| Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study JA Hirst, N Hill, CA O’Callaghan, D Lasserson, RJ McManus, E Ogburn, ... British Journal of General Practice 70 (693), e285-e293, 2020 | 104 | 2020 |
| The impact of renin–angiotensin–aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy JA Hirst, KS Taylor, RJ Stevens, CL Blacklock, NW Roberts, CW Pugh, ... Kidney international 81 (7), 674-683, 2012 | 62 | 2012 |
| Quantifying the effects of diuretics and β‐adrenoceptor blockers on glycaemic control in diabetes mellitus–a systematic review and meta‐analysis JA Hirst, AJ Farmer, BG Feakins, JK Aronson, RJ Stevens British journal of clinical pharmacology 79 (5), 733-743, 2015 | 60 | 2015 |
| Catalytic asymmetric synthesis of highly functionalised compounds with six contiguous stereocentres RA Aitken, J Gopal, JA Hirst Journal of the Chemical Society, Chemical Communications, 632-634, 1988 | 59 | 1988 |
| Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling R Perera, E McFadden, J McLellan, T Lung, P Clarke, T Pérez, ... Health Technology Assessment (Winchester, England) 19 (100), 1, 2015 | 58 | 2015 |
| Changes in HbA1c level over a 12-week follow-up in patients with type 2 diabetes following a medication change JA Hirst, RJ Stevens, AJ Farmer PloS one 9 (3), e92458, 2014 | 58 | 2014 |
| Diagnostic accuracy of point-of-care tests for detecting albuminuria: a systematic review and meta-analysis MP McTaggart, RG Newall, JA Hirst, CR Bankhead, EJ Lamb, ... Annals of internal medicine 160 (8), 550-557, 2014 | 55 | 2014 |
| Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment-systematic review and … AJ Farmer, R Stevens, J Hirst, T Lung, J Oke, P Clarke, P Glasziou, A Neil, ... Health technology assessment (Winchester, England) 18 (14), 1, 2014 | 50 | 2014 |
| Perceptions on undertaking regular asymptomatic self-testing for COVID-19 using lateral flow tests: a qualitative study of university students and staff M Wanat, M Logan, JA Hirst, C Vicary, JJ Lee, R Perera, I Tracey, G Duff, ... BMJ open 11 (9), e053850, 2021 | 48 | 2021 |
| Systematic review and metaanalysis comparing the bias and accuracy of the Modification of Diet in Renal Disease and Chronic Kidney Disease Epidemiology Collaboration equations … EC McFadden, JA Hirst, JY Verbakel, JH McLellan, FDR Hobbs, ... Clinical chemistry 64 (3), 475-485, 2018 | 40 | 2018 |
| Diuron degradation by Phanerochaete chrysosporium BKM- F-1767 in synthetic and natural media LE Fratila-Apachitei, JA Hirst, MA Siebel, HJ Gijzen Biotechnology letters 21 (2), 147-154, 1999 | 40 | 1999 |
| Evidence for a dose effect of renin–angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta‐analysis CL Blacklock, JA Hirst, KS Taylor, RJ Stevens, NW Roberts, AJ Farmer Diabetic medicine 28 (10), 1182-1187, 2011 | 38 | 2011 |
